People who don’t tell anyone else their HIV status have as good health outcomes as other people living with HIV
Many undiagnosed HIV infections picked up when testing people who have other medical conditions, but implementation challenges remain
Sofosbuvir-based treatment safe and effective in advanced kidney disease
Merck's grazoprevir/elbasvir combo cures 99% of hepatitis C in chronic kidney disease
Sofosbuvir plus pegylated interferon/ribavirin is highly effective for people with hard-to-treat genotype 3 hepatitis C
Sofosbuvir, daclatasvir and ribavirin cures hepatitis C for most people with advanced cirrhosis or liver transplants
New EASL guidelines prioritise interferon-free hepatitis C treatment
